Sidebar is Loading...
Loading...
Brands
Resources
Stories
YSTV
ADVERTISEMENT
Loading...
Brands
Resources
Stories
YSTV
Immuneel Therapeutics Pvt Ltd is a pioneering startup company leading the charge in cell therapy and personalized immunotherapy for patients.
Founded in 2019 by Kiran Mazumdar-Shaw, Founder and Chairperson of Biocon; US-based oncologist and author Dr Siddhartha Mukherjee; and Dr Kush Parmar, Founder of Boston-based 5AM Ventures; Immuneel Therapeutics offers cell and gene therapy to treat cancer at affordable prices in India. The company also announced that it has initiated patient dosing as part of phase II trials of its Chimeric Antigen Receptor T-cell therapy (CAR-T) to target blood cancer under the name IMAGINE at Narayana Hrudyalaya in Bengaluru. The trial is funded by Immuneel and will include 24 pediatric and adult cancer patients. The startup has exclusive rights to manufacture and commercialise the CAR-T cell therapy—currently under trial in India—from Hospital Clínic de Barcelona and Institut d’Investigacions Biomèdiques August Pi i Sunyer in Spain.
Legal Name
:
Immuneel Therapeutics Pvt Ltd
Headquarters
:
Bengaluru, Karnataka, India
Founding Date
:
2018
No. of Employees
:
41 to 60
Core Team
:
1.
Kiran Mazumdar-Shaw
Co-Founder
2.
Siddhartha Mukherjee
Co-Founder
3.
Kush Parmar
Co-Founder
Total Funding
$15.0M
Investors
:
1.
True North
2.
Eight Roads Ventures
3.
F-Prime Capital
Frequently Asked Questions
